Skip to content

Prestige Consumer Healthcare PBH Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Bausch + Lomb logo
Bausch + LombBLCO
Cardinal Health logo
Cardinal HealthCAH
Organon logo
OrganonOGN
Kenvue logo
KenvueKVUE
Abbott logo
AbbottABT
Clorox logo
CloroxCLX

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Prestige Consumer Healthcare’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's common stock, shares issued (in shares)?
Prestige Consumer Healthcare (PBH) reported common stock, shares issued (in shares) of $56.2M in Q4 2025.
How has Prestige Consumer Healthcare's common stock, shares issued (in shares) changed year-over-year?
Prestige Consumer Healthcare's common stock, shares issued (in shares) increased by 0.5% year-over-year, from $55.94M to $56.2M.
What is the long-term trend for Prestige Consumer Healthcare's common stock, shares issued (in shares)?
Over 4 years (2021 to 2025), Prestige Consumer Healthcare's common stock, shares issued (in shares) has grown at a 0.9% compound annual growth rate (CAGR), from $54M to $56.01M.